Development of the first myasthenia gravis patient registry in Latvia: a single-centre experience
Arta Grosmane-Bataraga, Vladimirs Krutovs, Marija Roddate, Violeta Žukova, Gundega Ķauķe, Ieva Glāzere, Linda Gailīte, Nataļja Kurjāne, Viktorija Ķēniņa · 2026
Read Development of the first myasthenia gravis patient registry in Latvia: a single-centre experience by Arta Grosmane-Bataraga, Vladimirs Krutovs, Marija Roddate, Violeta Žukova, Gundega Ķauķe, Ieva Glāzere, Linda Gailīte, Nataļja Kurjāne, Viktorija Ķēniņa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13458815.txt.
Description
Arta Grosmane-Bataraga and colleagues build Latvia's first myasthenia gravis patient list in a 2026 single-centre study. The disease, a rare immune disease of muscle weakness and fatigue, lacked long-term real-world data in Latvia. Adults with confirmed disease were recruited from January 2022 to May 2025 at Pauls Stradiņš Clinical University Hospital. They were assessed with standard severity, daily life, quality of life and fatigue scales, and stored in a secure digital list.
The list enrolled 112 patients across 523 visits, with median disease span 4.5 years and antibody profiles mostly AChR positive at 76 percent. Remission rose from 25 to 34 percent over a median 1.3 years, severe classes fell from 19 to 2 percent, and total, daily life and quality scores improved clearly, while fatigue eased only modestly and still affected half of patients. The list proves structured follow-up feasible and flags fatigue as the persistent burden.
Catalog record
| CREATOR | Arta Grosmane-Bataraga, Vladimirs Krutovs, Marija Roddate, Violeta Žukova, Gundega Ķauķe, Ieva Glāzere, Linda Gailīte, Nataļja Kurjāne, Viktorija Ķēniņa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |